Coldstream Capital Management Inc Amgen Inc Transaction History

Coldstream Capital Management Inc

$4.58 Billion
Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 28,646 shares of AMGN stock, worth $7.54 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

28,646

Previous 27,936 2.54%

Holding current value

$7.54 Million

Previous $8.73 Million 5.75%

% of portfolio

0.2%

Previous 0.21%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $219,659 - $239,539	710 Added 2.54%	28,646 $9.23 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $319,504 - $388,280	1,216 Added 4.55%	27,936 $8.73 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $57,807 - $69,780	215 Added 0.81%	26,720 $7.6 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $3.03 Million - $3.42 Million	11,839 Added 80.72%	26,505 $7.63 Million
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $967,307 - $1.2 Million	4,424 Added 43.19%	14,666 $3.94 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $51,639 - $61,062	-241 Reduced 2.3%	10,242 $2.27 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $56,447 - $68,800	-250 Reduced 2.33%	10,483 $2.53 Million
Q4 2022 Jan 10, 2023	SELL	$229.03 - $291.01 $1.1 Million - $1.4 Million	-4,798 Reduced 30.89%	10,733 $0
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $776,569 - $864,186	3,366 Added 27.67%	15,531 $3.78 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $444,578 - $494,737	-1,927 Reduced 13.67%	12,165 $2.96 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $321,230 - $355,365	1,465 Added 11.6%	14,092 $3.41 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $1.31 Million - $1.5 Million	-6,577 Reduced 34.25%	12,627 $2.84 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $2.94 Million - $3.45 Million	13,870 Added 260.03%	19,204 $4.88 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $112,819 - $125,164	483 Added 9.96%	5,334 $1.3 Million
Q1 2021 Jun 16, 2021	SELL	$221.91 - $258.6 $2.93 Million - $3.41 Million	-13,195 Reduced 73.12%	4,851 $1.21 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $237,368 - $282,663	1,097 Added 6.47%	18,046 $4.15 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $23,934 - $26,616	102 Added 0.61%	16,949 $4.31 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $285,242 - $350,031	-1,442 Reduced 7.88%	16,847 $3.97 Million
Q1 2020 May 27, 2020	SELL	$182.24 - $241.7 $178,777 - $237,107	-981 Reduced 5.09%	18,289 $3.71 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $36,895 - $47,424	195 Added 1.02%	19,270 $4.65 Million
Q3 2019 Nov 15, 2019	BUY	$174.11 - $208.62 $121,528 - $145,616	698 Added 3.8%	19,075 $3.69 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $25,505 - $29,897	-153 Reduced 0.83%	18,377 $3.39 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $221,927 - $250,160	1,227 Added 7.09%	18,530 $3.52 Million
Q4 2018 Feb 26, 2019	BUY	$178.4 - $208.25 $76,176 - $88,922	427 Added 2.53%	17,303 $3.37 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $133,964 - $151,027	723 Added 4.48%	16,876 $3.5 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $48,652 - $54,647	293 Added 1.85%	16,153 $2.98 Million
Q1 2018 May 16, 2018	SELL	$169.43 - $198.0 $99,455 - $116,226	-587 Reduced 3.57%	15,860 $2.7 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $87,602 - $97,878	519 Added 3.26%	16,447 $2.86 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $162,271 - $185,270	970 Added 6.48%	15,928 $2.97 Million
Q2 2017 Aug 15, 2017	BUY	N/A	14,958	14,958 $2.58 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Amgen Inc Transaction History